IP Verse

Boehringer Ingelheim vs. Zentiva Portugal - UPC_CFI_41/2025

The case UPC_CFI_41/2025 was filed by the plaintiff Boehringer Ingelheim against the defendant Zentiva Portugal on 22 Jan, 2025.

Case Timeline

22 Jan, 2025
Case Filed
21 Mar, 2025
Rejoinder
21 Mar, 2025
Interim Conference
21 Mar, 2025
Oral Procedure
Today Nov 1, 2025
Decision

Case Details

    Case Number:

    UPC_CFI_41/2025

    Patent Number:

    EP1830843

    Filing Date:

    22 Jan, 2025

    Proceeding Type:

    Provisionalmeasures

    Case Phase:

    Case Closed

    Plaintiffs:

    • Boehringer Ingelheim

    Plaintiff Representative:

    • Joana PIRIQUITO SANTOS

    Defendants:

    • Zentiva Portugal

    Defendant Representative:

    • Patricia Paias

    Judges:

    • Camille Lignieres
    • Petri Rinkinen
    • Rute Lopes

    Court Division:

    First Instance, Local Division - Lisbon

Case Decision

Decision pending - set alert to receive updates

Docket Entries

The docket entries provide a comprehensive overview of all filings, motions, orders, and other significant actions taken in the case.

Last updated on: Oct 30, 2025
DateTitle

Notify me when new UPC document is filed

May 26, 2025Outcome Of The Order
May 26, 2025Declaration
May 21, 2025Outcome Of The Order
May 16, 2025Template Order
May 16, 2025Measures Decisionoutcome Notification
May 16, 2025Declaration
May 8, 2025Final Order
Apr 22, 2025Request To The Registrar For The Recording Of The Oral Hearing To Be Made Available
Apr 22, 2025Receipt
Apr 16, 2025Template Order
Apr 16, 2025Record
Apr 16, 2025Receipt
Apr 16, 2025Final Order Purposes
Apr 15, 2025Request Recording Oral Hearing
Apr 10, 2025Response Under Order April 2,
Apr 10, 2025Response Under App 15653
Apr 9, 2025Receipt
Apr 8, 2025Generic Procedural Appplication
Apr 8, 2025Decision And Final Report Under Framework Agreement Part 5
Apr 8, 2025Decision And Final Report Under Framework Agreement Part 4
Apr 8, 2025Decision And Final Report Under Framework Agreement Part 3
Apr 8, 2025Decision And Final Report Under Framework Agreement Part 2
Apr 8, 2025Decision And Final Report Under Framework Agreement Part 1
Apr 8, 2025Call For Proposals Under Framework Agreement (Reference:) Part 1
Apr 8, 2025Call For Proposals Under Framework Agreement Part 4
Apr 8, 2025Call For Proposals Under Framework Agreement Part 3
Apr 8, 2025Call For Proposals Under Framework Agreement Part 2
Apr 7, 2025Response Under Order Of April 2,
Apr 7, 2025Response Under Order App 15653. Of April 2,
Apr 7, 2025Receipt
Apr 7, 2025Exhibit 27
Apr 7, 2025Exhibit 26
Apr 7, 2025Exhibit 2
Apr 7, 2025Exhibit 1 Permanent Certificate
Apr 7, 2025Exhibit 1
Apr 7, 2025Applicant'S Note On Award Of Costs
Apr 4, 2025Bi Reply To Zentiva Evidence Submission
Apr 2, 2025Receipt
Apr 2, 2025Order
Mar 31, 2025Written Statement Ana Teixeira
Mar 31, 2025Written Statement Ana Lopes
Mar 31, 2025Receipt
Mar 31, 2025Order
Mar 31, 2025Exhibit 25 Defence Spms
Mar 31, 2025Exhibit 24 Defence Zentiva
Mar 31, 2025Exhibit 23 Article Prof. Marco Caldeira
Mar 31, 2025Exhibit 22 Zentiva Atos Societarios
Mar 31, 2025Exhibit 21 Declaration Manuela Kreuder
Mar 31, 2025Exhibit 20 Declaration Vanessa Jacinto
Mar 31, 2025Application Written
Mar 31, 2025Application For Written Witnesses Statements
Mar 28, 2025Generic Procedural Appplication
Mar 28, 2025Exhibit 1 Tpi Decision
Mar 24, 2025Receipt
Mar 21, 2025Rejoinder
Mar 21, 2025Exhibit 4 Order 1771 B 2016
Mar 21, 2025Exhibit 3 Decree Law 19 2010
Mar 21, 2025Exhibit 2 Order 55 2013
Mar 21, 2025Exhibit 1 Proof Of Judicial Certificate
Mar 13, 2025Receipt
Mar 12, 2025Reply To The Objection
Mar 12, 2025Exhibit 19
Mar 12, 2025Exhibit 18
Mar 12, 2025Exhibit 17
Mar 7, 2025Request Remit To Objection Filed 03.03
Mar 7, 2025Acknowledgement Of Lodging
Mar 6, 2025Summon Oral Hearing
Mar 6, 2025Order
Mar 3, 2025Template Order
Mar 3, 2025Receipt
Mar 3, 2025Order 209.1(B) Rop
Mar 3, 2025Oral Hearing
Mar 3, 2025Objection Provisional Measures Application
Mar 3, 2025Exhibit 5 Clarification Boehringer Ingelheim Portugal 30.01
Mar 3, 2025Exhibit 4 Specifications Framework Agreement No 491 Part 4
Mar 3, 2025Exhibit 4 Specifications Framework Agreement No 491 Part 3
Mar 3, 2025Exhibit 4 Specifications Framework Agreement No 491 Part 2
Mar 3, 2025Exhibit 4 Specifications Framework Agreement No 491 Part 1
Mar 3, 2025Exhibit 3 Framework Agreement Nintedanib Part 3
Mar 3, 2025Exhibit 3 Framework Agreement Nintedanib Part 2
Mar 3, 2025Exhibit 3 Framework Agreement Nintedanib Part 1
Mar 3, 2025Exhibit 2 Case 57/25.1Yhlsb Part 3
Mar 3, 2025Exhibit 2 Case 57/25.1Yhlsb Part 2
Mar 3, 2025Exhibit 2 Case 57/25.1Yhlsb (I)
Mar 3, 2025Exhibit 1 Certificate Spc 679
Feb 24, 2025Acknowledgement Of Access To Case
Feb 10, 2025Receipt Confirmation
Feb 10, 2025Notification Of Service
Jan 30, 2025Letter For Service
Jan 29, 2025Template Order
Jan 29, 2025Preliminary Order R
Jan 29, 2025Panel Appointment
Jan 23, 2025Response To The Request For Amendments
Jan 23, 2025Proof Of Payment Of Court Fees
Jan 23, 2025Formal Checks Notification Of Positive Outcome
Jan 23, 2025Exhibit 9 Zentiva Generics Mas: Infomed Extract (Pt And Eng)
Jan 23, 2025Exhibit 8 Decision Of China National Intellectual Property Administration
Jan 23, 2025Exhibit 7 Decision Of The Federal Court Of Canada
Jan 23, 2025Exhibit 6 EP1830843B1 Decision Of The Od Of The Epo
Jan 23, 2025Exhibit 5 Boehringer Ingelheim Pharma Gmbh & Co. Kg Authorization
Jan 23, 2025Exhibit 4 EP1830843B1 Epo Registrar And National Registrars
Jan 23, 2025Exhibit 3 EP1830843B1
Jan 23, 2025Exhibit 2 Ofev Summary Of Product Characteristics And Package Leaflet
Jan 23, 2025Exhibit 1 Boehringer Ingelheim Pharma Gmbh & Co. Kg Authorized Boehringer Ingelheim International Gmbh To File To Proc
Jan 23, 2025Exhibit 16 Written Statement From Mariana Nascimento
Jan 23, 2025Exhibit 15 Iqvia Data
Jan 23, 2025Exhibit 14 EP1830843B1Opt Out And Withdrawal Of The Opt Out
Jan 23, 2025Exhibit 13 Notice No. (Pt And En)
Jan 23, 2025Exhibit 12 Zentiva Generics Smpc And Pl (Pt And En)
Jan 23, 2025Exhibit 11 Zentiva: Authorised And Registered Wholesale Distributor Of Medicines
Jan 23, 2025Exhibit 10 Zentiva Generics: Dcp Procedure
Jan 23, 2025Application For Provisional Measures
Jan 23, 2025Application For Measures Receipt
Jan 22, 2025Formal Checks Request For Correction
Jan 21, 2025Proof Of Payment Of Court Fees
Jan 21, 2025Exhibit 9 Zentiva Generics Mas: Infomed Extract (Pt And Eng)
Jan 21, 2025Exhibit 8 Decision Of China National Intellectual Property Administration
Jan 21, 2025Exhibit 7 Decision Of The Federal Court Of Canada
Jan 21, 2025Exhibit 6 EP1830843B1 Decision Of The Od Of The Epo
Jan 21, 2025Exhibit 5 Boehringer Ingelheim Pharma Gmbh & Co. Kg Authorization
Jan 21, 2025Exhibit 4 EP1830843B1 Epo Registrar And National Registrars
Jan 21, 2025Exhibit 3 EP1830843B1
Jan 21, 2025Exhibit 2 Ofev Summary Of Product Characteristics And Package Leaflet
Jan 21, 2025Exhibit 1 Boehringer Ingelheim Pharma Gmbh & Co. Kg Authorized Boehringer Ingelheim International Gmbh To File To Proc
Jan 21, 2025Exhibit 16 Written Statement From Mariana Nascimento
Jan 21, 2025Exhibit 15 Iqvia Data
Jan 21, 2025Exhibit 14 EP1830843B1Opt Out And Withdrawal Of The Opt Out
Jan 21, 2025Exhibit 13 Notice No. (Pt And En)
Jan 21, 2025Exhibit 12 Zentiva Generics Smpc And Pl (Pt And En)
Jan 21, 2025Exhibit 11 Zentiva: Authorised And Registered Wholesale Distributor Of Medicines
Jan 21, 2025Exhibit 10 Zentiva Generics: Dcp Procedure
Jan 21, 2025Application For Provisional Measures
Jan 21, 2025Application For Measures Acknowledgement

More cases involving EP1830843B1

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 30, 2025
Case NumberFiling DatePlaintiffsDefendants
APL_24205/2025May 23, 2025Boehringer IngelheimZentiva Portugal
UPC_COA_446/2025May 23, 2025Boehringer IngelheimZentiva Portugal
ACT_3186/2025Jan 22, 2025Boehringer IngelheimZentiva Portugal

More cases involving Boehringer Ingelheim

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 30, 2025
Case NumberFiling DatePlaintiffsDefendants
APP_33288/2025Jul 21, 2025Boehringer Ingelheim -
APL_24205/2025May 23, 2025Boehringer IngelheimZentiva Portugal
UPC_COA_446/2025May 23, 2025Boehringer IngelheimZentiva Portugal

More cases involving Zentiva Portugal

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 30, 2025
Case NumberFiling DatePlaintiffsDefendants
APL_24205/2025May 23, 2025Boehringer IngelheimZentiva Portugal
UPC_COA_446/2025May 23, 2025Boehringer IngelheimZentiva Portugal
ORD_24048/2025May 20, 2025NovartisZentiva Portugal